Ameriprise’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25M Sell
382,595
-8,237
-2% -$537K 0.01% 1217
2025
Q1
$26.2M Buy
390,832
+119,027
+44% +$7.97M 0.01% 1160
2024
Q4
$15M Buy
271,805
+34,586
+15% +$1.91M ﹤0.01% 1519
2024
Q3
$14.2M Buy
237,219
+3,865
+2% +$231K ﹤0.01% 1531
2024
Q2
$14.9M Sell
233,354
-9,920
-4% -$632K ﹤0.01% 1466
2024
Q1
$16.8M Buy
243,274
+6,880
+3% +$476K ﹤0.01% 1411
2023
Q4
$13M Sell
236,394
-11,019
-4% -$608K ﹤0.01% 1576
2023
Q3
$14.4M Sell
247,413
-10,499
-4% -$610K ﹤0.01% 1442
2023
Q2
$13.9M Sell
257,912
-43,653
-14% -$2.35M ﹤0.01% 1512
2023
Q1
$12M Sell
301,565
-30
-0% -$1.19K ﹤0.01% 1617
2022
Q4
$12.1M Sell
301,595
-4,615
-2% -$186K ﹤0.01% 1583
2022
Q3
$9.84M Buy
306,210
+2,702
+0.9% +$86.8K ﹤0.01% 1689
2022
Q2
$9.01M Sell
303,508
-9,965
-3% -$296K ﹤0.01% 1822
2022
Q1
$8.81M Buy
313,473
+30,396
+11% +$855K ﹤0.01% 2015
2021
Q4
$13M Buy
283,077
+9,132
+3% +$421K ﹤0.01% 1755
2021
Q3
$8.99M Sell
273,945
-1,322
-0.5% -$43.4K ﹤0.01% 1939
2021
Q2
$9.65M Buy
275,267
+31,934
+13% +$1.12M ﹤0.01% 1967
2021
Q1
$8.8M Buy
243,333
+9,687
+4% +$350K ﹤0.01% 1986
2020
Q4
$6.79M Buy
233,646
+24,873
+12% +$722K ﹤0.01% 2042
2020
Q3
$5.89M Buy
208,773
+155,208
+290% +$4.38M ﹤0.01% 1960
2020
Q2
$1.73M Sell
53,565
-3,078
-5% -$99.5K ﹤0.01% 2681
2020
Q1
$2.31M Buy
56,643
+1,516
+3% +$61.8K ﹤0.01% 2402
2019
Q4
$3.4M Sell
55,127
-2,331
-4% -$144K ﹤0.01% 2461
2019
Q3
$4.19M Sell
57,458
-54,803
-49% -$3.99M ﹤0.01% 2305
2019
Q2
$9.23M Sell
112,261
-5,130
-4% -$422K ﹤0.01% 1801
2019
Q1
$8.28M Sell
117,391
-17,172
-13% -$1.21M ﹤0.01% 1862
2018
Q4
$6.06M Sell
134,563
-6,095
-4% -$274K ﹤0.01% 1992
2018
Q3
$7.95M Buy
140,658
+57,533
+69% +$3.25M ﹤0.01% 2042
2018
Q2
$5.55M Buy
83,125
+28,896
+53% +$1.93M ﹤0.01% 2176
2018
Q1
$3.16M Buy
54,229
+1,184
+2% +$68.9K ﹤0.01% 2470
2017
Q4
$3.42M Sell
53,045
-715
-1% -$46.1K ﹤0.01% 2372
2017
Q3
$2.82M Sell
53,760
-445
-0.8% -$23.4K ﹤0.01% 2435
2017
Q2
$2.54M Buy
54,205
+340
+0.6% +$15.9K ﹤0.01% 2492
2017
Q1
$2.67M Buy
53,865
+1,000
+2% +$49.5K ﹤0.01% 2443
2016
Q4
$3.2M Buy
52,865
+1,153
+2% +$69.9K ﹤0.01% 2383
2016
Q3
$3.43M Buy
51,712
+2,827
+6% +$188K ﹤0.01% 2256
2016
Q2
$2.73M Buy
48,885
+5,925
+14% +$331K ﹤0.01% 2360
2016
Q1
$1.45M Buy
42,960
+1,880
+5% +$63.2K ﹤0.01% 2681
2015
Q4
$1.85M Sell
41,080
-23,030
-36% -$1.04M ﹤0.01% 2641
2015
Q3
$2.53M Sell
64,110
-2,527
-4% -$99.8K ﹤0.01% 2474
2015
Q2
$4.13M Buy
66,637
+3,277
+5% +$203K ﹤0.01% 2267
2015
Q1
$3.96M Buy
63,360
+9,895
+19% +$619K ﹤0.01% 2228
2014
Q4
$3.02M Buy
53,465
+28,860
+117% +$1.63M ﹤0.01% 2355
2014
Q3
$696K Buy
24,605
+12,655
+106% +$358K ﹤0.01% 2931
2014
Q2
$412K Buy
+11,950
New +$412K ﹤0.01% 3062